Treatment of severe alcoholic hepatitis: A systematic review
Authors:
- 1 October 2021
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 60, 91-101
Abstract
No abstract availableKeywords
Funding Information
- Vlaamse regering
- Fonds Wetenschappelijk Onderzoek (1110121N)
This publication has 51 references indexed in Scilit:
- Corticosteroid Plus Pentoxifylline Is Not Better than Corticosteroid Alone for Improving Survival in Severe Alcoholic Hepatitis (COPE Trial)Digestive Diseases and Sciences, 2012
- Pentoxifylline Does Not Decrease Short-term Mortality but Does Reduce Complications in Patients With Advanced CirrhosisGastroenterology, 2010
- Pentoxifylline versus prednisolone for severe alcoholic hepatitis: A randomized controlled trialWorld Journal of Gastroenterology, 2009
- The Lille model: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroidsHepatology, 2007
- Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis—A randomised clinical trialJournal of Hepatology, 2006
- A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitisHepatology, 2004
- Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: A multicenter randomized trialHepatology, 2000
- Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisoloneGastroenterology, 1996
- Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: A randomized controlled trialHepatology, 1991
- Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis.Gut, 1982